Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)

This study has been completed.
Sponsor:
Collaborator:
Sigma Tau Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
ClinicalTrials.gov Identifier:
NCT00984750
First received: September 23, 2009
Last updated: February 22, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)